Ashwagandha Dosage: How Much KSM-66 or Sensoril to Take

Ashwagandha dosage questions go wrong in one predictable place: people compare milligrams across extracts as if milligrams were the active ingredient. They are not. The active fraction is withanolides, the extracts concentrate them differently, and the trials dosed each extract on its own terms. This page gives you the studied ranges for the two named extracts that dominate the research — KSM-66 and Sensoril — plus the timing and duration rules that matter as much as the number. If you have not read the safety picture yet, start with our main ashwagandha guide; dosage without safety is how careful people end up in case reports.

Why does the extract name change the dose?

KSM-66 is a root-only extract, standardized to at least 5 percent withanolides, built to resemble the root ratio used traditionally. Most of its trials — stress, sleep, strength, cognition — used 600 mg a day, very often as 300 mg twice daily, with some trials at 300 mg a day. Sensoril is a root-and-leaf extract standardized to at least 10 percent withanolide glycosides. Its trials, concentrated on stress, used 125 to 250 mg a day. Leaf inclusion changes the chemistry, the higher standardization changes the math, and the studied dose drops accordingly.

No trial has compared the two extracts head-to-head, so nobody can honestly declare a winner. What you can declare is a matching rule: the dose belongs to the extract. Taking 600 mg of Sensoril because 600 mg worked for KSM-66 doubles the top studied Sensoril exposure for no reason. Taking 125 mg of generic powder because Sensoril worked at 125 mg borrows a concentrated extract’s credibility for an unconcentrated product. Both errors fill supplement forums. Avoid both by reading which extract — if any — is actually in your bottle.

Extract	Source and standardization	Studied daily dose	Best-studied uses
KSM-66	Root only, at least 5% withanolides	300 to 600 mg	Stress, sleep, strength, cognition
Sensoril	Root + leaf, at least 10% withanolide glycosides	125 to 250 mg	Stress
Shoden	Root + leaf, high withanolide glycosides	About 120 mg in its sleep trial	Sleep (single-trial support)
Plain root powder	Root, unstandardized or lightly standardized	Grams per day traditionally	Least trial support

What dose matches your goal?

For stress support, the center of the evidence is 600 mg a day of KSM-66 — the dose in the frequently cited sixty-day trial where cortisol and stress scores fell — or 125 to 250 mg a day of Sensoril if that is your extract. Lower KSM-66 doses around 250 to 300 mg appear in some trials with smaller or absent effects on some outcomes, which is why this page presents 300 mg as a starting step, not the studied destination, for people who want to test tolerance first.

For sleep, the dose bar is higher and the calendar is longer. The NIH fact sheet notes that sleep benefits seemed most helpful at 600 mg a day or more for at least eight weeks, and the KSM-66 sleep trials dosed 300 mg twice daily for eight to ten weeks. Our ashwagandha for sleep guide explains why a stress-mediated herb needs those weeks, and how it differs from the direct ingredients in the sleep stack. For general use, expect the same patience across goals: trials measured at about eight weeks, some at twelve. A dose judged at day nine has not been judged at all.

How should you time and split the dose?

Twice-daily splitting — 300 mg morning and 300 mg evening for KSM-66 — is the pattern in many trials and smooths exposure across the day. Once-daily dosing also appears and is easier to sustain. Choose based on your response: if ashwagandha makes you drowsy, weight the dose toward the evening; if evening dosing leaves you groggy at dawn, move it earlier; if your goal is sleep, an evening-weighted split fits the trial logic best. Take it with food if your stomach complains — upset stomach and loose stools are the commonest side effects on the NIH list, detailed in our ashwagandha side effects page.

Do not chase speed with loading doses. Nothing in the trial record supports front-loading ashwagandha, and the side-effect curve rises with dose while the benefit curve, such as it is, rises with weeks. The discipline that works is dull: same extract, same dose, same times, eight weeks, then a verdict. Change one variable and you no longer know what you tested. That discipline is also your safety system, because the rare liver-injury pattern in case reports typically appears two to twelve weeks in — inside your trial window, where a new symptom should stop the experiment, not be dosed through.

What about root powder and unstandardized products?

Plain root powder is the traditional form, used at gram-level amounts — commonly one to several grams a day in traditional practice — and it is the form with the least modern trial support. A 600 mg capsule of powder is not equivalent to 600 mg of KSM-66 extract, and labels that imply equivalence are miscounting on purpose. If you prefer powder for cost or tradition, understand you are outside the dosage evidence on this page, your withanolide exposure is lower and more variable, and the safety cautions — thyroid, sedatives, pregnancy, liver — apply in full regardless of form. Natural and gentle are not synonyms, and root powder is still Withania somnifera.

Whatever form you choose, buy standardization you can read: extract name, part used, withanolide percentage, and milligrams per capsule, ideally with third-party testing. A label that says only proprietary blend with a total weight has told you nothing dosable, and undisclosed doses are disqualifying on this site for exactly that reason.

What happens if you miss doses or stop and restart?

Life interrupts eight-week protocols, and the trial record offers a forgiving read on that: ashwagandha’s effects, where they exist, build from cumulative daily exposure over weeks, not from perfect streaks or blood levels timed to the hour. A missed day needs no doubling up — doubling is how mild stomach upset becomes the day’s main event. Resume the studied dose the next day and extend your judgment window by roughly the time you missed. If you stop for two or more weeks, treat a restart as a new trial at the starting dose, especially if the break was caused by illness, new medication, or any symptom from the safety list, each of which changes the calculation more than the calendar does.

Cycling is the related question every forum asks and no trial answers directly. Because safety is described to about three months and unclear beyond it, the conservative pattern many clinicians favor is a defined on-period at a studied dose, a review, and an off-period — rather than indefinite daily use drifting across years. There is no evidence that cycling preserves effectiveness, and this page will not invent a ratio of weeks on to weeks off. What the evidence does support is humility about duration: the absence of long-term data is itself the finding, and your dosage plan should be built around it, with a clinician in the loop for any use that stretches past a single season.

Does body weight or food change the dose?

Students of the trials ask this often, and the honest answer is that the studies dosed flat amounts, not milligrams per kilogram — 300 or 600 mg of KSM-66, 125 or 250 mg of Sensoril — across ordinary adult weight ranges, with no weight-based adjustment reported. There is no evidence base for scaling your dose up because you are larger, and the side-effect logic argues against inventing one. Take the studied flat dose for your extract, and let your eight-week result, not a formula, decide whether the trial continues.

Food is the variable that does matter in practice. The trials and the tolerability record both point the same way: doses taken with meals produce less nausea and stomach upset, and splitting the daily amount across two meals is the gentlest pattern of all. A dose that reliably upsets an empty stomach will end your trial by week two regardless of its evidence, so build the habit around breakfast and dinner from day one. Consistency of routine beats precision of timing for this herb at every level the data can see.

Who should not take this?

Dosage guidance does not apply to you at all if you are pregnant or breastfeeding — ashwagandha should be avoided in pregnancy and its safety while breastfeeding is unknown — or if you are under 18 outside medical advice. Do not self-dose if you have a thyroid disorder, an autoimmune condition, hormone-sensitive prostate cancer, or liver disease: the NIH flags each of these, and no milligram table overrides them. Talk to your doctor or pharmacist first if you take thyroid medication, sedatives or anti-seizure medication, immunosuppressants, or diabetes or blood-pressure drugs, all listed as potential interactions in the NIH fact sheet. Stop and seek care for yellowing skin or eyes, dark urine, severe itching, racing heart or tremor, or heavy sedation. This page describes studied ranges for healthy adults; it is not a prescription. Talk to your doctor or pharmacist before starting.